LR

Linga Reddy Churukanti

Active Director Managing Director DIN 02031783
DIN 02031783 First appointment Feb 2008 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 6 active board seats
Past companies 8 historical roles
Total affiliations 14 Since Feb 2008
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 18 Feb 2008
Active appointments 8
Total timeline records 14

Linga Reddy Churukanti (DIN 02031783) has 14 recorded board appointments in Indian companies, the first from February 2008, of which 8 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2008
Quinnharper Pharmaceuticals Private Limited Director · 2024 – present
Current
Anewa Lifesciences Private Limited Director · 2024 – present
Current
Vals Pharma Private Limited Director · 2020 – present
Current
Sushee Pharma Private Limited Director · 2017 – present
Current
Uniloids Solvents Private Limited Director · 2011 – present
Current
Cgs Assets Private Limited Director · 2010 – present
Current
Bio-Vin Pharmaceuticals (Hyderabad) Private Limited Managing Director · 2008 – present
Current
Bio-Vin Research Laboratories Private Limited Managing Director · 2008 – present
Current
Rxkart Medical Private Limited Additional Director · 2024 – 2024
Previous
Joshika Pharma Private Limited Director · 2022 – 2022
Previous
Asb Laboratories Private Limited Director · 2017 – 2024
Previous
Synergy Remedies Private Limited Director · 2014 – 2016
Previous
Arene Life Sciences Private Limited Director · 2010 – 2014
Previous
Uniloids Biosciences Private Limited Director · 2010 – 2013
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available